WuXi AppTec Co., Ltd. (WUXIF)
USD 7.12
(0.0%)
USD 7.12
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 14.16 Billion CNY | 15.37% |
| 2022 | 12.41 Billion CNY | 76.47% |
| 2021 | 7.36 Billion CNY | 57.09% |
| 2020 | 4.51 Billion CNY | 38.6% |
| 2019 | 3.26 Billion CNY | 2.68% |
| 2018 | 3.21 Billion CNY | 47.05% |
| 2017 | 2.04 Billion CNY | 23.69% |
| 2016 | 1.56 Billion CNY | 50.13% |
| 2015 | 1.15 Billion CNY | 67.55% |
| 2014 | 692.75 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 2.44 Billion CNY | -0.68% |
| 2024 Q3 | 2.84 Billion CNY | -5.19% |
| 2024 Q2 | 3 Billion CNY | 22.7% |
| 2023 Q2 | 4.14 Billion CNY | 64.9% |
| 2023 FY | - CNY | 15.37% |
| 2023 Q1 | 2.51 Billion CNY | -20.32% |
| 2023 Q3 | 3.33 Billion CNY | -19.54% |
| 2023 Q4 | 2.46 Billion CNY | -26.06% |
| 2022 Q3 | 2.25 Billion CNY | -37.49% |
| 2022 Q1 | 2.05 Billion CNY | 101.48% |
| 2022 FY | - CNY | 76.47% |
| 2022 Q2 | 3.61 Billion CNY | 75.76% |
| 2022 Q4 | 3.15 Billion CNY | 39.6% |
| 2021 FY | - CNY | 57.09% |
| 2021 Q4 | 1.02 Billion CNY | -38.29% |
| 2021 Q2 | 1.76 Billion CNY | 15.88% |
| 2021 Q1 | 1.51 Billion CNY | 42.61% |
| 2021 Q3 | 1.65 Billion CNY | -6.06% |
| 2020 Q2 | 1.5 Billion CNY | 181.53% |
| 2020 Q1 | 536.11 Million CNY | 247.82% |
| 2020 Q3 | 737.44 Million CNY | -51.14% |
| 2020 FY | - CNY | 38.6% |
| 2020 Q4 | 1.06 Billion CNY | 44.44% |
| 2019 Q4 | 154.13 Million CNY | -84.26% |
| 2019 Q2 | 667.85 Million CNY | 3.7% |
| 2019 Q1 | 644.03 Million CNY | -37.76% |
| 2019 FY | - CNY | 2.68% |
| 2019 Q3 | 979.28 Million CNY | 46.63% |
| 2018 Q1 | 381.91 Million CNY | -21.82% |
| 2018 FY | - CNY | 47.05% |
| 2018 Q2 | 589.19 Million CNY | 54.27% |
| 2018 Q4 | 1.03 Billion CNY | 79.48% |
| 2018 Q3 | 576.52 Million CNY | -2.15% |
| 2017 FY | - CNY | 23.69% |
| 2017 Q4 | 488.49 Million CNY | 12.12% |
| 2017 Q3 | 435.67 Million CNY | -16.33% |
| 2017 Q1 | 457.44 Million CNY | 0.0% |
| 2017 Q2 | 520.69 Million CNY | 13.83% |
| 2016 FY | - CNY | 50.13% |
| 2015 FY | - CNY | 67.55% |
| 2014 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | 1218428.995% |
| Arrayit Corporation | -3.07 Million USD | 460512.323% |
| Atlantic International Corp. | -5.38 Million USD | 263000.241% |
| Biocept, Inc. | -30.24 Million USD | 46954.159% |
| Bioqual, Inc. | 3.03 Million USD | -467183.797% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | 1870925.709% |
| DermTech, Inc. | -97.89 Million USD | 14574.136% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | -386.225% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 70097.261% |
| iMD Companies, Inc. | -154.65 Thousand USD | 9161652.971% |
| IDenta Corp. | 71.58 Thousand USD | -19792831.971% |
| Interpace Biosciences, Inc. | 3.83 Million USD | -369177.201% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | -36622195.709% |
| InVitro International | 6680.00 USD | -212113166.617% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | 260754.272% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | 116772526.323% |
| Medical Imaging Corp. | -896.74 Thousand USD | 1580171.661% |
| NovelStem International Corp. | -3.78 Million USD | 374371.487% |
| Optigenex Inc. | -1.18 Million USD | 1194073.174% |
| PharmChem, Inc. | 1.05 Million USD | -1344465.549% |
| Proteome Sciences plc | -1.13 Million USD | 1246288.761% |
| Response Genetics, Inc | -19.66 Million USD | 72149.05% |
| Rennova Health, Inc. | -234.81 Thousand USD | 6034282.744% |
| RushNet, Inc. | -614.85 Thousand USD | 2304584.04% |
| ScreenPro Security Inc. | -3.43 Million USD | 412607.252% |
| Stella Diagnostics Inc. | -5.7 Million USD | 248358.257% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | 138064.684% |
| Todos Medical Ltd. | -9.39 Million USD | 150932.087% |